Literature DB >> 28708320

Monosomy 7/del (7q) in inherited bone marrow failure syndromes: A systematic review.

Alex Pezeshki1, Shreya Podder2, Ralph Kamel2, Seth J Corey2.   

Abstract

Inherited bone marrow failure syndromes (IBMFS) are rare cancer predisposition syndromes with an especially high risk of transformation to myelodysplastic syndrome (MDS) and/or acute myeloid leukemia (AML). We performed a retrospective systematic review of reported MDS/AML arising in the eight most common IBMFS to determine the frequency and outcome of chromosome 7 abnormalities. We identified 738 MDS/AML cases of 4,293 individuals. Monosomy 7 or del (7q) occurred in ∼17%. Greater understanding of the roles played by sequential acquisition of genetic and cytogenetic changes will provide insights into myeloid leukemogenesis and improve the surveillance and hopefully outcomes for individuals with IBMFS.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute myeloid leukemia; bone marrow failure syndromes; monosomy 7

Mesh：

Year:  2017        PMID： 28708320      PMCID： PMC5937691          DOI： 10.1002/pbc.26714

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  22 in total

1.  Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.

Authors:  Brady L Stein; Donna M Williams; Christine O'Keefe; Ophelia Rogers; Roxann G Ingersoll; Jerry L Spivak; Amit Verma; Jarek P Maciejewski; Michael A McDevitt; Alison R Moliterno
Journal:  Haematologica       Date:  2011-06-28       Impact factor: 9.941

2.  Underlying undiagnosed inherited marrow failure syndromes among children with cancer.

Authors:  Fahad Alabbas; Sheila Weitzman; Ronald Grant; Eric Bouffet; David Malkin; Oussama Abla; Yigal Dror
Journal:  Pediatr Blood Cancer       Date:  2016-08-31       Impact factor: 3.167

3.  A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC system.

Authors:  Karen Mandel; Yigal Dror; Annette Poon; Melvin H Freedman
Journal:  J Pediatr Hematol Oncol       Date:  2002 Jun-Jul       Impact factor: 1.289

4.  Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients.

Authors:  S Luna-Fineman; K M Shannon; S K Atwater; J Davis; M Masterson; J Ortega; J Sanders; P Steinherz; V Weinberg; B J Lange
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

5.  New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.

Authors:  Detlef Haase; Ulrich Germing; Julie Schanz; Michael Pfeilstöcker; Thomas Nösslinger; Barbara Hildebrandt; Andrea Kundgen; Michael Lübbert; Regina Kunzmann; Aristoteles A N Giagounidis; Carlo Aul; Lorenz Trümper; Otto Krieger; Reinhard Stauder; Thomas H Müller; Friedrich Wimazal; Peter Valent; Christa Fonatsch; Christian Steidl
Journal:  Blood       Date:  2007-08-28       Impact factor: 22.113

Review 6.  Pediatric myelodysplastic syndromes: they do exist!

Authors:  Taly Glaubach; Lisa J Robinson; Seth J Corey
Journal:  J Pediatr Hematol Oncol       Date:  2014-01       Impact factor: 1.289

7.  Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis.

Authors:  Jasmine C Wong; Kelley M Weinfurtner; Maria Del Pilar Alzamora; Scott C Kogan; Michael R Burgess; Yan Zhang; Joy Nakitandwe; Jing Ma; Jinjun Cheng; Shann-Ching Chen; Theodore T Ho; Johanna Flach; Damien Reynaud; Emmanuelle Passegué; James R Downing; Kevin Shannon
Journal:  Elife       Date:  2015-07-20       Impact factor: 8.140

8.  Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

9.  Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

Authors:  Marios Dimitriou; Petter S Woll; Teresa Mortera-Blanco; Mohsen Karimi; David C Wedge; Helen Doolittle; Iyadh Douagi; Elli Papaemmanuil; Sten Eirik W Jacobsen; Eva Hellström-Lindberg
Journal:  Oncotarget       Date:  2016-11-08

10.  Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.

Authors:  Sang Mee Hwang; Seon Young Kim; Jung Ah Kim; Hee-Sue Park; Si Nae Park; Kyongok Im; Kwantae Kim; Sung-Min Kim; Dong Soon Lee
Journal:  J Hematol Oncol       Date:  2016-07-28       Impact factor: 17.388
View more
  5 in total

Review 1.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 2.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

3.  Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms.

Authors:  Molly K Imgruet; Julian Lutze; Ningfei An; Bonnie Hu; Saira Khan; Jeffrey Kurkewich; Tanner C Martinez; Donald Wolfgeher; Sandeep K Gurbuxani; Stephen J Kron; Megan E McNerney
Journal:  Blood       Date:  2021-09-02       Impact factor: 25.476

Review 4.  Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.

Authors:  Serine Avagyan; Akiko Shimamura
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

Review 5.  Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists.

Authors:  Elena Crisà; Paola Boggione; Maura Nicolosi; Abdurraouf Mokhtar Mahmoud; Wael Al Essa; Bassel Awikeh; Anna Aspesi; Annalisa Andorno; Renzo Boldorini; Irma Dianzani; Gianluca Gaidano; Andrea Patriarca
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.